Gilead Raday
Chief Operating Officer at RedHill Biopharma · 2 reported transactions in 1 company · latest trade Oct 1, 2026
Their trades
Sold | Oct 1, 2026 | Oct 1, 2026 close $0.48 → Oct 22, 2026 close $0.42. S&P 500 +0.0% over the same days. | ||
Sold | Jul 10, 2026 | Jul 10, 2026 close $0.69 → Oct 22, 2026 close $0.42. S&P 500 +1.2% over the same days. |
14,310,000
Oct 1, 2026 close $0.48 → Oct 22, 2026 close $0.42. S&P 500 +0.0% over the same days.
14,130,000
Jul 10, 2026 close $0.69 → Oct 22, 2026 close $0.42. S&P 500 +1.2% over the same days.